ArticleInvestigational new drugs2017

Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553).

Susanne M Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.